SK86996A3 - Bicyclic compounds, manufacturing process thereof, pharmaceutical agent containing them and their use - Google Patents

Bicyclic compounds, manufacturing process thereof, pharmaceutical agent containing them and their use Download PDF

Info

Publication number
SK86996A3
SK86996A3 SK869-96A SK86996A SK86996A3 SK 86996 A3 SK86996 A3 SK 86996A3 SK 86996 A SK86996 A SK 86996A SK 86996 A3 SK86996 A3 SK 86996A3
Authority
SK
Slovakia
Prior art keywords
carbonyl
tetrahydro
oxo
methylamino
ethyl
Prior art date
Application number
SK869-96A
Other languages
English (en)
Slovak (sk)
Inventor
William E Bondinell
James F Callahan
William F Huffman
Richard M Keenan
Thomas Wen-Fu Ku
Kenneth A Newlander
James M Samanen
Irene N Uzinskas
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of SK86996A3 publication Critical patent/SK86996A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D223/16—Benzazepines; Hydrogenated benzazepines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)
SK869-96A 1994-01-07 1995-01-09 Bicyclic compounds, manufacturing process thereof, pharmaceutical agent containing them and their use SK86996A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US17901194A 1994-01-07 1994-01-07
PCT/US1995/000248 WO1995018619A1 (fr) 1994-01-07 1995-01-09 Antagonistes de fibrinogene bicycliques

Publications (1)

Publication Number Publication Date
SK86996A3 true SK86996A3 (en) 1997-02-05

Family

ID=22654859

Family Applications (1)

Application Number Title Priority Date Filing Date
SK869-96A SK86996A3 (en) 1994-01-07 1995-01-09 Bicyclic compounds, manufacturing process thereof, pharmaceutical agent containing them and their use

Country Status (27)

Country Link
US (1) US6117866A (fr)
EP (1) EP0738150B1 (fr)
JP (1) JPH09508620A (fr)
KR (1) KR100388772B1 (fr)
CN (1) CN1117569C (fr)
AP (1) AP542A (fr)
AT (1) ATE238993T1 (fr)
AU (1) AU699186B2 (fr)
BG (2) BG62844B1 (fr)
BR (1) BR9506499A (fr)
CZ (1) CZ292323B6 (fr)
DE (1) DE69530571T2 (fr)
DK (1) DK0738150T3 (fr)
ES (1) ES2197914T3 (fr)
HK (1) HK1014668A1 (fr)
HU (1) HUT76282A (fr)
IL (1) IL112243A (fr)
MA (1) MA23420A1 (fr)
NO (1) NO962859L (fr)
NZ (1) NZ279394A (fr)
OA (1) OA10368A (fr)
PT (1) PT738150E (fr)
SG (1) SG64884A1 (fr)
SK (1) SK86996A3 (fr)
TW (1) TW420682B (fr)
WO (1) WO1995018619A1 (fr)
ZA (1) ZA9545B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458784B1 (en) * 1994-06-29 2002-10-01 Smithkline Beecham Corporation Vitronectin receptor antagonists
EP0762882A4 (fr) * 1994-06-29 2002-09-11 Smithkline Beecham Corp Antagonistes du recepteur de la vibronectine
EP0777657A1 (fr) * 1994-08-22 1997-06-11 Smithkline Beecham Corporation Composés bicycliques
DE19516483A1 (de) * 1995-05-05 1996-11-07 Merck Patent Gmbh Adhäsionsrezeptor-Antagonisten
ZA9610853B (en) 1995-12-29 1998-04-06 Smithkline Beecham Corp Processes and intermediates for preparing pharmaceuticals.
IL128782A0 (en) * 1996-09-03 2000-01-31 Smithkline Beecham Corp Crystalline pharmaceutical product
ZA9711566B (en) * 1996-12-27 1998-06-29 Smithkline Beecham Plc Enzymatic resolution.
AU745169B2 (en) * 1997-12-09 2002-03-14 Ihara Chemical Industry Co. Ltd. Process for producing toluene derivatives
US6548663B1 (en) 1998-03-31 2003-04-15 Bristol-Myers Squibb Pharma Company Benzodiazepine vitronectin receptor antagonist pharmaceuticals
US6569402B1 (en) 1998-12-18 2003-05-27 Bristol-Myers Squibb Pharma Company Vitronectin receptor antagonist pharmaceuticals
EP1140864A2 (fr) 1998-12-18 2001-10-10 Du Pont Pharmaceuticals Company Medicaments antagonistes du recepteur de la vitronectine
GB9908662D0 (en) * 1999-04-15 1999-06-09 Smithkline Beecham Plc Novel process for preparing benzodiazepines
CO5180550A1 (es) 1999-04-19 2002-07-30 Smithkline Beecham Corp Inhibidores de fab i
CO5370679A1 (es) 1999-06-01 2004-02-27 Smithkline Beecham Corp Inhibidores fab 1
US6762201B1 (en) 1999-10-08 2004-07-13 Affinium Pharmaceuticals, Inc. Fab I inhibitors
CZ302015B6 (cs) 1999-10-08 2010-09-08 Affinium Pharmaceuticals, Inc. Inhibitory Fab I
US6730684B1 (en) 1999-10-08 2004-05-04 Affinium Pharmaceuticals, Inc. Fab I inhibitors
SE9904377D0 (sv) * 1999-12-01 1999-12-01 Astra Pharma Prod Pharmaceutical combinations
US6964974B2 (en) * 2000-09-08 2005-11-15 Hoffmann-La Roche Inc. 2,3-oxidosqualene-lanosterol cyclase inhibitors
ES2320984T3 (es) 2001-04-06 2009-06-01 Affinium Pharmaceuticals, Inc. Inhibidores de fab i.
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US7766013B2 (en) 2001-06-05 2010-08-03 Alexza Pharmaceuticals, Inc. Aerosol generating method and device
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
CA2464472C (fr) 2001-10-22 2014-01-07 The Scripps Research Institute Composes de ciblage d'anticorps
WO2004036181A2 (fr) * 2002-10-17 2004-04-29 The Trustees Of The University Of Pennsylvania Procede de traitement de maladies et de troubles neurologiques
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
JP2007516149A (ja) 2003-05-21 2007-06-21 アレックザ ファーマシューティカルズ， インコーポレイテッド 基板温度の均一性を制御する方法、および、内蔵式加熱ユニットおよびそれを使用する薬剤供給ユニット
GB0321256D0 (en) * 2003-09-11 2003-10-08 Generics Uk Ltd Novel crystalline compounds
EP1677783A2 (fr) 2003-10-08 2006-07-12 Nicholas Piramal India Limited Antagonistes du recepteur du fibrinogene et leur utilisation
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
WO2007048127A2 (fr) * 2005-10-20 2007-04-26 The Scripps Research Institute MARQUAGE DE PARTIES Fc POUR L'IMMUNOCOLORATION ET L'IMMUNOCIBLAGE
EP2687533B1 (fr) 2006-07-20 2017-07-19 Debiopharm International SA Dérivés d'acrylamide en tant qu'inhibiteurs de FAB I
EP2125802A4 (fr) 2007-02-16 2014-08-20 Debiopharm Int Sa Sels, promédicaments et polymorphes d'inhibiteurs de fab 1
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
EP2395992A2 (fr) 2009-02-10 2011-12-21 The Scripps Research Institute Vaccination programmée chimiquement
TR201909016T4 (tr) 2012-06-19 2019-07-22 Debiopharm Int Sa (E)-n-metil-n-((3-metilbenzofuran-2-il)metil)-3-(7-okso-5,6,7,8-tetrahidro-1,8-naftiridin-3-il)akrilamidin ön ilaç türevleri.
KR20180114177A (ko) 2016-02-26 2018-10-17 데비오팜 인터네셔날 에스 에이 당뇨병성 족부 감염의 치료제

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1592552A (en) * 1976-12-10 1981-07-08 Inst Nat Sante Rech Med Pseudopeptides used as medicaments
LU77316A1 (fr) * 1977-05-11 1979-01-19
CA1145333A (fr) * 1980-02-08 1983-04-26 Quirico Branca Derives de benzodiazepine
CA1163266A (fr) * 1980-07-31 1984-03-06 Albert E. Fischli Derives de benzodiazepine
CA1157855A (fr) * 1980-07-31 1983-11-29 Albert E. Fischli Derives de benzodiazepine
NL8005133A (nl) * 1980-09-12 1982-04-01 Duphar Int Res Fenylpiperazinederivaten met antiagressieve werking.
US4410520A (en) * 1981-11-09 1983-10-18 Ciba-Geigy Corporation 3-Amino-[1]-benzazepin-2-one-1-alkanoic acids
ZA833214B (en) * 1982-05-12 1983-12-28 Hoffmann La Roche Bicyclic compounds
US5059688A (en) * 1982-06-14 1991-10-22 Hoechst-Roussel Pharmaceuticals Inc. 1-aryloxy-2,3,4,5-tetrahydro-3-benzazepine preparation
DE3418271A1 (de) * 1984-05-17 1985-11-21 Dr. Karl Thomae Gmbh, 7950 Biberach Neue benzazepinderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US4820834A (en) * 1984-06-26 1989-04-11 Merck & Co., Inc. Benzodiazepine analogs
EP0204349A3 (fr) * 1985-06-01 1990-01-03 Dr. Karl Thomae GmbH Dérivés d'amines hétéroaromatiques, médicaments les contenant et procédé pour leur préparation
EP0275748B1 (fr) * 1986-12-15 1992-08-19 Institut National De La Sante Et De La Recherche Medicale (Inserm) Nouveaux dérivés peptidiques et leur application notamment en thérapeutique
DE3702755A1 (de) * 1987-01-30 1988-08-11 Hoechst Ag 3,5-di-tert.-butyl-4-hydroxybenzoesaeureamid, verschiedene von dessen derivaten, verfahren zur herstellung dieser verbindungen, die sie enthaltenden arzneimittel und ihre verwendung
WO1989005150A1 (fr) * 1987-12-10 1989-06-15 La Jolla Cancer Research Foundation Peptides d'adhesion cellulaire a stabilisation conformationnelle
DK107688D0 (da) * 1988-03-01 1988-03-01 Novo Industri As Carbaminsyreestere af substituerede 7-hydroxy-2,3,4,5-tetrahydro-1h-3-benzazepiner
ZW6189A1 (en) * 1988-05-09 1990-05-09 Smithkline Beckman Corp Anti-aggregatory peptides
FR2634207B1 (fr) * 1988-07-12 1990-09-07 Synthelabo Derives de ((piperidinyl-4)methyl) benzazepines, leur preparation et leur application en therapeutique
US5039805A (en) * 1988-12-08 1991-08-13 Hoffmann-La Roche Inc. Novel benzoic and phenylacetic acid derivatives
US5084466A (en) * 1989-01-31 1992-01-28 Hoffmann-La Roche Inc. Novel carboxamide pyridine compounds which have useful pharmaceutical utility
ES2052172T3 (es) * 1989-03-23 1994-07-01 Pfizer Agentes antialergicos basados en diazepina.
JPH04211071A (ja) * 1990-03-05 1992-08-03 Hokuriku Seiyaku Co Ltd 多環式化合物
NZ239846A (en) * 1990-09-27 1994-11-25 Merck & Co Inc Sulphonamide derivatives and pharmaceutical compositions thereof
IL99537A (en) * 1990-09-27 1995-11-27 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical preparations containing them
NZ239876A (en) * 1990-09-27 1993-12-23 Merck & Co Inc Glycyl-b-alanine derivatives and pharmaceutical compositions thereof.
IL99539A0 (en) * 1990-09-27 1992-08-18 Merck & Co Inc Fibrinogen receptor antagonists and pharmaceutical compositions containing them
WO1992007568A1 (fr) * 1990-11-01 1992-05-14 Smithkline Beecham Corporation IMITATEURS DE PEPTIDES A TORSION η COMME ANTAGONISTES DES FIBRINOGENES
AU9122391A (en) * 1990-11-30 1992-06-25 Smithkline Beecham Corporation Hiv protease inhibitors
US5321034A (en) * 1991-05-07 1994-06-14 Merck & Co., Inc. Fibrinogen receptor antagonists
EP0523845A3 (en) * 1991-06-14 1993-11-18 Merck & Co Inc New benzodiazepine analogs
EP0593603B1 (fr) * 1991-06-28 2002-11-20 Smithkline Beecham Corporation Antagonistes bicycliques de fibrinogene
US5250679A (en) * 1991-10-18 1993-10-05 Genentech, Inc. Nonpeptidyl platelet aggregation inhibitors having specificity for the GPIIb III.sub. receptor
US5663166A (en) * 1991-10-18 1997-09-02 Genentech, Inc. Nonpeptidyl integrin inhibitors having specificity for the GPIIb IIIa receptor
US5149699A (en) * 1991-10-24 1992-09-22 American Home Products Corporation Substituted pyridopyrimidines useful as antgiotensin II antagonists
US5241065A (en) * 1992-02-25 1993-08-31 Schering Corporation 2,3,4,5-tetrahydro-1h-3-benzazepines having anti-psychotic activity
DK0667866T3 (da) * 1992-11-09 1998-05-25 Knoll Ag 1,4-benzothiazepiner anvendelige som neurologiske midler
DE69332860T2 (de) * 1992-12-21 2004-03-11 Smithkline Beecham Corp. Bicyklische fibrinogen antagoniste
US5493020A (en) * 1993-07-29 1996-02-20 Genentech, Inc. Tricyclic inhibitors of the GPIIb IIIa receptor
EP0762882A4 (fr) * 1994-06-29 2002-09-11 Smithkline Beecham Corp Antagonistes du recepteur de la vibronectine

Also Published As

Publication number Publication date
EP0738150A1 (fr) 1996-10-23
CZ292323B6 (cs) 2003-09-17
IL112243A0 (en) 1995-03-30
IL112243A (en) 1999-12-31
DK0738150T3 (da) 2003-08-25
OA10368A (en) 2001-11-15
ES2197914T3 (es) 2004-01-16
MA23420A1 (fr) 1995-10-01
US6117866A (en) 2000-09-12
TW420682B (en) 2001-02-01
ATE238993T1 (de) 2003-05-15
JPH09508620A (ja) 1997-09-02
CZ198196A3 (en) 1997-06-11
PT738150E (pt) 2003-08-29
AU1600195A (en) 1995-08-01
WO1995018619A1 (fr) 1995-07-13
CN1143323A (zh) 1997-02-19
DE69530571D1 (de) 2003-06-05
NO962859D0 (no) 1996-07-05
BR9506499A (pt) 1997-09-09
EP0738150A4 (fr) 1997-03-19
ZA9545B (en) 1996-01-23
EP0738150B1 (fr) 2003-05-02
AP9500710A0 (en) 1995-01-31
NZ279394A (en) 1998-05-27
BG100698A (bg) 1997-02-28
BG62844B1 (bg) 2000-09-29
HU9601849D0 (en) 1996-09-30
BG102863A (en) 1999-05-31
AP542A (en) 1996-10-01
NO962859L (no) 1996-09-05
WO1995018619A9 (fr) 2004-10-21
HK1014668A1 (en) 1999-09-30
AU699186B2 (en) 1998-11-26
KR100388772B1 (ko) 2003-11-20
CN1117569C (zh) 2003-08-13
SG64884A1 (en) 1999-05-25
HUT76282A (en) 1997-07-28
DE69530571T2 (de) 2004-03-04

Similar Documents

Publication Publication Date Title
SK86996A3 (en) Bicyclic compounds, manufacturing process thereof, pharmaceutical agent containing them and their use
AU689762B2 (en) Bicyclic fibrinogen antagonists
US6300342B1 (en) Antithrombotic phenylalkyl derivatives
US6677369B2 (en) Antithrombotic agents
EP0691960B1 (fr) Derives anti-psychotiques de benzimidazole
US5521170A (en) Benzamide derivatives and pharmaceutical composition comprising the same
JP2001509815A (ja) 二置換二環式複素環化合物、これらの調製及び医薬組成物としてのこれらの使用
JP2000513375A (ja) フィブリノーゲンレセプター拮抗薬プロドラッグ
KR20010083087A (ko) 벤즈이미다졸, 이의 제조방법 및 약제로서의 이의 용도
CA2197789A1 (fr) Derives cycliques d'uree; compositions pharmaceutiques renfermant ces coomposes et methodes de preparation
US6403578B1 (en) Bicyclic fibrinogen antagonists
EP0800395A1 (fr) Antagonistes des recepteurs du fibrinogene
AU4380301A (en) Bicyclic fibrinogen antagonists
MXPA99011261A (en) Phenylalkyl derivatives with thrombin-inhibiting effect
CA2180441A1 (fr) Antagonistes de fibrinogene bicycliques